Bruker Reports Third Quarter 2023 Financial Results

Q3 2023 revenues of $742.8 million, up 16.3% year-over-year ; organic revenue up 10.9% yoy



Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy



Bruker increases FY 2023 revenue guidance to...

Related Keywords

Taiwan ,Israel ,Russia ,United States ,Ukraine ,China ,Frankh Laukien ,Bruker Biospin ,Bruker Nano ,Asia Pacific ,Exchange Commission ,Securities Exchange ,Bruker Corporation ,Bruker Corporation Nasdaq ,Bruker Energy Supercon Technologies ,Phenomex Inc ,Scientific Instruments ,Supercon Technologies ,Nine Months ,Cellular Analysis ,Bruker Cellular Analysis ,Investor Relations ,Securities Act ,Securities Exchange Act ,Purchase Agreement ,Before Tax ,Per Share ,Cash Flow ,Invested Capital ,Tax Provision ,Revenue Growth ,Organic Revenue ,Organic Revenue Growth ,Bruker Scientific Instruments ,Nano Segments ,Markets ,